Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

Back

ESC Professional Premium Access

Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

Session: Diabetes and the heart (3)

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Speaker: Doctor I. Ikonomidis (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

5 presentations

3 followers

6 more presentations in this session

Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

Speaker: Professor G. Jong (Taichung, TW)

Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD

Speaker: Doctor P. Thrane (Aarhus, DK)

Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease

Speaker: Doctor M. Hansen (Aarhus, DK)

The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease

Speaker: Doctor K. Olesen (Aarhus, DK)

Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Speaker: Doctor B. Nilsson Wadstrom (Copenhagen, DK)

Access the full session

Diabetes and the heart (3)

Speakers: Doctor I. Ikonomidis, Professor G. Jong, Doctor P. Thrane, Doctor M. Hansen, Doctor K. Olesen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources